Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Net Margin (2019 - 2025)

Silo Pharma's Net Margin history spans 7 years, with the latest figure at 6160.54% for Q3 2025.

  • For Q3 2025, Net Margin fell 100762.0% year-over-year to 6160.54%; the TTM value through Sep 2025 reached 7041.12%, down 189031.0%, while the annual FY2024 figure was 6092.59%, 599606.0% down from the prior year.
  • Net Margin for Q3 2025 was 6160.54% at Silo Pharma, up from 6681.24% in the prior quarter.
  • Across five years, Net Margin topped out at 663832.93% in Q4 2021 and bottomed at 1321970.81% in Q3 2021.
  • The 5-year median for Net Margin is 5537.3% (2022), against an average of 41512.18%.
  • The largest annual shift saw Net Margin tumbled -131807891bps in 2021 before it surged 131651591bps in 2022.
  • A 5-year view of Net Margin shows it stood at 663832.93% in 2021, then plummeted by -101bps to 9218.17% in 2022, then surged by 37bps to 5833.66% in 2023, then tumbled by -65bps to 9600.69% in 2024, then soared by 36bps to 6160.54% in 2025.
  • Per Business Quant, the three most recent readings for SILO's Net Margin are 6160.54% (Q3 2025), 6681.24% (Q2 2025), and 5721.94% (Q1 2025).